Projected Effects of Radiation-Induced Cancers on Life Expectancy in Patients Undergoing CT Surveillance for Limited-Stage Hodgkin Lymphoma: A Markov Model
Authors
Lowry, Kathryn P.Turan, Ekin A.
Eisenberg, Jonathan
Kong, Chung Y.
Barnes, Jeffrey A.
Pandharipande, Pari Vijay
Faculty Advisor
Pari Pandharipande, MD, MPH/Mass. General Hospital – Institute for Technology AssessmentDocument Type
Journal ArticlePublication Date
2015-06-01Keywords
AdultAged
Boston
Causality
Comorbidity
Computer Simulation
Female
Hodgkin Disease
Humans
Incidence
*Life Expectancy
Male
Markov Chains
Middle Aged
*Models, Statistical
Neoplasm Staging
Neoplasms, Radiation-Induced
Population Surveillance
Proportional Hazards Models
Reproducibility of Results
Risk Assessment
Sensitivity and Specificity
*Survival Analysis
Tomography, X-Ray Computed
Young Adult
Neoplasms
Radiology
Metadata
Show full item recordAbstract
OBJECTIVE: Patients with limited-stage Hodgkin lymphoma (HL) undergo frequent posttreatment surveillance CT examinations, raising concerns about the cumulative magnitude of radiation exposure. The purpose of this study was to project radiation-induced cancer risks relative to competing risks of HL and account for the differential timing of each. MATERIALS AND METHODS: We adapted a previously developed Markov model to project lifetime mortality risks and life expectancy losses due to HL versus radiation-induced cancers in HL patients undergoing surveillance CT. In the base case, we modeled 35-year-old men and women undergoing seven CT examinations of the chest, abdomen, and pelvis over 5 years. Radiation-induced cancer risks and deaths for 17 organ systems were modeled using an organ-specific approach, accounting for specific anatomy exposed at CT. Cohorts of 20-, 50-, and 65-year-old men and women were evaluated in secondary analyses. Markov chain Monte Carlo methods were used to estimate the uncertainty of radiation risk projections. RESULTS: For 35-year-old adults, we projected 3324/100,000 (men) and 3345/100,000 (women) deaths from recurrent lymphoma and 245/100,000 (men, 95% uncertainty interval [UI]: 121-369) and 317/100,000 (women, 95% UI: 202-432) radiation-induced cancer deaths. Discrepancies in life expectancy losses between HL (428 days in men, 482 days in women) and radiation-induced cancers (11.6 days in men, [95% UI: 5.7-17.5], 15.6 days in women [95% UI: 9.8-21.4]) were proportionately greater because of the delayed timing of radiation-induced cancers relative to recurrent HL. Deaths and life expectancy losses from radiation-induced cancers were highest in the youngest cohorts. CONCLUSION: Given the low rate of radiation-induced cancer deaths associated with CT surveillance, modest CT benefits would justify its use in patients with limited-stage HL.Source
AJR Am J Roentgenol. 2015 Jun;204(6):1228-33. doi: 10.2214/AJR.14.13287. Link to article on publisher's siteDOI
10.2214/AJR.14.13287Permanent Link to this Item
http://hdl.handle.net/20.500.14038/49286PubMed ID
26001232Notes
Jonathan Eisenberg participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.
Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.2214/AJR.14.13287